269 related articles for article (PubMed ID: 37301862)
21. Design and optimization of piperlongumine analogs as potent senolytics.
Zhang X; He Y; Liu X; Zhang X; Shi P; Wang Y; Zhou D; Zheng G
Bioorg Med Chem Lett; 2024 Jan; 98():129593. PubMed ID: 38104906
[TBL] [Abstract][Full Text] [Related]
22. Strategies for late phase preclinical and early clinical trials of senolytics.
Wissler Gerdes EO; Misra A; Netto JME; Tchkonia T; Kirkland JL
Mech Ageing Dev; 2021 Dec; 200():111591. PubMed ID: 34699859
[TBL] [Abstract][Full Text] [Related]
23. A p21-GFP zebrafish model of senescence for rapid testing of senolytics in vivo.
Morsli S; Henriques CM; Ellis PS; Mortiboys H; Baxendale S; Loynes CA; Renshaw SA; Bellantuono I
Aging Cell; 2023 Jun; 22(6):e13835. PubMed ID: 37039087
[TBL] [Abstract][Full Text] [Related]
24. Recent Advances in Senotherapeutics Delivery.
Choi JY; Yee SF; Tchangalova T; Yang G; Fisher JP
Tissue Eng Part B Rev; 2022 Dec; 28(6):1223-1234. PubMed ID: 35451328
[TBL] [Abstract][Full Text] [Related]
25. Senotherapeutics in Cancer and HIV.
Sánchez-Díaz L; Espinosa-Sánchez A; Blanco JR; Carnero A
Cells; 2022 Apr; 11(7):. PubMed ID: 35406785
[TBL] [Abstract][Full Text] [Related]
26. Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span.
Robbins PD; Jurk D; Khosla S; Kirkland JL; LeBrasseur NK; Miller JD; Passos JF; Pignolo RJ; Tchkonia T; Niedernhofer LJ
Annu Rev Pharmacol Toxicol; 2021 Jan; 61():779-803. PubMed ID: 32997601
[TBL] [Abstract][Full Text] [Related]
27. Supramolecular Senolytics via Intracellular Oligomerization of Peptides in Response to Elevated Reactive Oxygen Species Levels in Aging Cells.
Kim S; Chae JB; Kim D; Park CW; Sim Y; Lee H; Park G; Lee J; Hong S; Jana B; Kim C; Chung H; Ryu JH
J Am Chem Soc; 2023 Oct; 145(40):21991-22008. PubMed ID: 37664981
[TBL] [Abstract][Full Text] [Related]
28. Cellular Senescence and Senolytic Agents: Recent Updates on Their Role and Applications.
Chandrakar L; Ambatwar R; Khatik GL
Curr Top Med Chem; 2024; 24(2):157-178. PubMed ID: 38037999
[TBL] [Abstract][Full Text] [Related]
29. Insights into targeting cellular senescence with senolytic therapy: The journey from preclinical trials to clinical practice.
Chen P; Wang Y; Zhou B
Mech Ageing Dev; 2024 Apr; 218():111918. PubMed ID: 38401690
[TBL] [Abstract][Full Text] [Related]
30. Senotherapeutics to Counteract Senescent Cells Are Prominent Topics in the Context of Anti-Ageing Strategies.
Calabrò A; Accardi G; Aiello A; Caruso C; Galimberti D; Candore G
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339070
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic Potential of Senolytics in Cardiovascular Disease.
Dookun E; Passos JF; Arthur HM; Richardson GD
Cardiovasc Drugs Ther; 2022 Feb; 36(1):187-196. PubMed ID: 32979174
[TBL] [Abstract][Full Text] [Related]
32. Senolytic drugs: from discovery to translation.
Kirkland JL; Tchkonia T
J Intern Med; 2020 Nov; 288(5):518-536. PubMed ID: 32686219
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological Targeting of Senescence with Senolytics as a New Therapeutic Strategy for Neurodegeneration.
Richardson M; Richardson DR
Mol Pharmacol; 2024 Jan; 105(2):64-74. PubMed ID: 38164616
[TBL] [Abstract][Full Text] [Related]
34. New Horizons in cellular senescence for clinicians.
Witham MD; Granic A; Miwa S; Passos JF; Richardson GD; Sayer AA
Age Ageing; 2023 Jul; 52(7):. PubMed ID: 37466640
[TBL] [Abstract][Full Text] [Related]
35. Increased cellular senescence in doxorubicin-induced murine ovarian injury: effect of senolytics.
Gao Y; Wu T; Tang X; Wen J; Zhang Y; Zhang J; Wang S
Geroscience; 2023 Jun; 45(3):1775-1790. PubMed ID: 36648735
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the HDAC/PI3K inhibitor CUDC-907 as a novel senolytic.
Al-Mansour F; Alraddadi A; He B; Saleh A; Poblocka M; Alzahrani W; Cowley S; Macip S
Aging (Albany NY); 2023 Mar; 15(7):2373-2394. PubMed ID: 36988504
[TBL] [Abstract][Full Text] [Related]
37. A pipeline for senolytics.
Khosla S
J Clin Invest; 2024 May; 134(9):. PubMed ID: 38690734
[TBL] [Abstract][Full Text] [Related]
38. [Senolytics against Covid-19?].
Jordan B
Med Sci (Paris); 2021 Nov; 37(11):1062-1065. PubMed ID: 34851287
[TBL] [Abstract][Full Text] [Related]
39. Senolytics: Opening avenues in drug discovery to find novel therapeutics for Parkinson's Disease.
Kakoty V; Kalarikkal Chandran S; Gulati M; Goh BH; Dua K; Kumar Singh S
Drug Discov Today; 2023 Jun; 28(6):103582. PubMed ID: 37023942
[TBL] [Abstract][Full Text] [Related]
40. Senotherapeutics: Targeting senescent cells for the main age-related diseases.
Boccardi V; Mecocci P
Mech Ageing Dev; 2021 Jul; 197():111526. PubMed ID: 34166689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
